Market Overview

UPDATE: ISI Group Initiates CVS Caremark at Overweight, $53.50 PT

Related CVS
CVS Caremark Announces New Clinical Affiliation With MedStar Health
Top 4 Stocks In The Drug Stores Industry With The Highest Dividend Yield
Rite Aid Halves 1Q Profit as Costs Grow (Fox Business)
Related CVS
CVS Caremark Announces New Clinical Affiliation With MedStar Health
Top 4 Stocks In The Drug Stores Industry With The Highest Dividend Yield
Rite Aid Halves 1Q Profit as Costs Grow (Fox Business)

ISI Group initiated its coverage on CVS Caremark (NYSE: CVS) with a rating of Overweight and a price target of $53.50.

ISI Group commented, "Our thesis for CVS is based on our view of continued share gain at the pharmacy given the success of Maintenance Choice and the continuation of the WAG/ESRX dispute, improved growth and profitability at Caremark as a result of innovative solutions and the streamlining initiative, and a very shareholder friendly approach to capital deployment and enhanced capital returns."

CVS Caremark closed at $46.90 on Wednesday.

Posted-In: ISI GroupAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (CVS)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters